Here are five things to know:
1. The agreement covers Bacterin’s line of biologic implants, including the 3Demin cortical fiber allografts.
2. The contract extends through June 2018.
3. Yankee Alliance is the first group purchasing organization to include Bacterin’s family of allografts. The allografts were developed for the bone replacement market, which is a $1.7 billion annual business segment.
4. The 3Demin was launched in late 2014, and the company experienced positive adoption of the allograft categories since then. Bacterin anticipates this growth will continue.
5. Bacterin serves as a contracted biologics supplier for Premier, which has an affiliation with Yankee Alliance.
More articles on orthopedic devices:
Integra LifeSciences receives high momentum style score
Blue Belt, SurgCenter Development partner for orthopedic robots
Arthrex, DePuy Synthes, Implanet & more—18 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
